Clinical trials
Nasopharyngeal Carcinoma trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 5 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 5 |
| Chinese University of Hong Kong | 4 |
| Novartis Pharmaceuticals | 3 |
| Cullinan Therapeutics Inc. | 1 |
| NRG Oncology | 1 |
| National Cancer Institute (NCI) | 1 |
| Pamela Youde Nethersole Eastern Hospital | 1 |
| RAPT Therapeutics, Inc., a member of the GSK plc group of companies | 1 |
| Viracta Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 18 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Nasopharyngeal Neoplasms | 3 |
| Epstein-Barr Virus Infections | 2 |
| Melanoma | 2 |
| Recurrence | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Anus Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.